Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypothalamic appetite-regulating neurons comprise multiple, molecularly distinct populations located primarily in the arcuate nucleus (ARC), paraventricular, dorsomedial, ventromedial, and lateral hypothalamic areas. Key neuronal subtypes include POMC/CART-expressing (anorexigenic) neurons and NPY/AgRP-expressing (orexigenic) neurons, which integrate peripheral metabolic and hormonal signals (such as leptin, insulin, ghrelin, GLP-1, and CCK) to regulate feeding and energy homeostasis. These neurons project to and receive input from other hypothalamic and extrahypothalamic centers, orchestrating the balance between hunger and satiety, and are implicated in obesity, eating disorders, and metabolic diseases. This term describes a neuronal category and not a discrete molecular therapeutic target in the classical pharmacological sense.
Drugs modulate signaling of peripheral hormones (leptin, ghrelin, insulin) or neurotransmitters (NPY, AgRP, POMC-derived peptides, CART, orexin) affecting these neurons to alter satiety/appetite signals
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypothalamic appetite-regulating neuron.